PIEZO1 and osteoporosis: The specific Piezo1 agonist Yoda1 enhances osteoblast mineralization ability in vitro and significantly increases bone density in mouse models, partially reversing osteoporosis (Guan et al., 2024; Ochiai et al., 2024; Hao et al., 2024).